Muscle regeneration is a dynamic process during which cell state and identity change over time. A major roadblock has been a lack of tools to resolve a myogenic progression in vivo. Here we capitalize on a transformative technology, single-cell mass cytometry (CyTOF), to identify in vivo skeletal muscle stem cell and previously unrecognized progenitor populations that precede differentiation. We discovered two cell surface markers, CD9 and CD104, whose combined expression enabled in vivo identification and prospective isolation of stem and progenitor cells. Data analysis using the X-shift algorithm paired with single-cell force-directed layout visualization defined a molecular signature of the activated stem cell state (CD44 + /CD98 + /MyoD + ) and delineated a myogenic trajectory during recovery from acute muscle injury. Our studies uncover the dynamics of skeletal muscle regeneration in vivo and pave the way for the elucidation of the regulatory networks that underlie cell-state transitions in muscle diseases and ageing.
Muscle regeneration is a dynamic process during which cell state and identity change over time. A major roadblock has been a lack of tools to resolve a myogenic progression in vivo. Here we capitalize on a transformative technology, single-cell mass cytometry (CyTOF), to identify in vivo skeletal muscle stem cell and previously unrecognized progenitor populations that precede differentiation. We discovered two cell surface markers, CD9 and CD104, whose combined expression enabled in vivo identification and prospective isolation of stem and progenitor cells. Data analysis using the X-shift algorithm paired with single-cell force-directed layout visualization defined a molecular signature of the activated stem cell state (CD44 + /CD98 + /MyoD + ) and delineated a myogenic trajectory during recovery from acute muscle injury. Our studies uncover the dynamics of skeletal muscle regeneration in vivo and pave the way for the elucidation of the regulatory networks that underlie cell-state transitions in muscle diseases and ageing.
Adult muscle stem cells (MuSCs) drive skeletal muscle repair and regeneration 1 . Normally quiescent during homeostasis, MuSCs become activated following muscle injury to replenish the stem cell pool, and simultaneously give rise to progeny that will differentiate and repair the damage 2 . While the role and phenotype of stem cells in muscle regeneration has been extensively studied, little is known about the myogenic progenitor stage, due to the lack of tools to capture this transient cell population in vivo.
In haematopoiesis, the identification and isolation of haematopoietic stem and progenitor cells by standard cell sorting methods 3 and single-cell mass cytometry 4 have enabled the discovery of the key pathways that go awry at specific stages of development 5, 6 , profoundly impacting the treatment of a multitude of blood diseases 3, 7 . Similarly, the elucidation of myogenic progenitors in vivo has the potential to define the key molecular events that govern cell-state transitions during the course of regeneration, and drive the development of therapeutic strategies for muscle diseases.
To address the cellular and molecular complexity of the myogenic compartment, a major challenge in the muscle field, we applied a highdimensional single-cell platform called mass cytometry, also known as cytometry by time of flight (CyTOF). CyTOF enables the simultaneous measurements of up to 50 parameters per single cell using antibodies conjugated to metal isotopes 4, 8 . The multidimensional attribute of CyTOF allowed us to identify previously unrecognized progenitor cell populations in vivo, on the basis of surface marker combinations, and to determine their role during muscle regeneration. This study defines an in vivo developmental progression from stem to progenitor cells in skeletal muscle, providing the foundation for future studies of cellular signalling dysfunction within these myogenic populations in the context of ageing, dystrophy and other disease states. Moreover, it paves the way for future investigations of such cell populations in other systems.
RESULTS

Identification of a myogenic progression in vivo by single-cell mass cytometry
To discover surface markers that could uniquely distinguish between myogenic stem and progenitor cells in vivo in skeletal muscle, we performed a high-throughput fluorescence-based flow cytometry screen with 176 antibodies to integral membrane proteins in both MuSCs, isolated from Pax7-ZsGreen reporter mice 9 , and myoblasts, a primary culture system used to study the late stages of myogenic differentiation and fusion. Flow cytometry data analysis identified several surface markers (Fig. 1a ), for which antibodies were then included in our CyTOF panel on the basis of two criteria: presence of the markers on either MuSCs or myoblasts; differential expression levels on MuSCs versus myoblasts. In addition, the screen confirmed the expression on Pax7-ZsGreen MuSCs of known markers previously used to isolate MuSCs, such as α7 integrin and CD34 (ref. 10) , β1 integrin/CD29 and CXCR4/CD184 (ref. 11) , and VCAM/CD106 (ref. 12) (Fig. 1a) .
To identify myogenic progenitors in vivo within skeletal muscle, we capitalized on the CyTOF technology and assembled a panel of 23 isotope-conjugated antibodies. These reagents were used to simultaneously measure, at the single-cell level, the expression of previously unrecognized surface markers revealed in our screen, known surface proteins used to isolate MuSCs by us and others, and myogenic transcription factors known to define distinct stages of myogenesis 1 (Supplementary Table 1 and Supplementary Fig. 1a-d ). Single-cell suspensions of hindlimb muscles, gastrocnemius (GA) and tibialis anterior (TA) were prepared from 8-week-old mice as described previously 10 and processed for CyTOF analysis (Fig. 1b) . To distinguish stem and progenitor cell populations, we analysed the CyTOF data set with a recently developed K-nearest-neighbour densitybased clustering algorithm called X-shift 13 , which performed unsupervised clustering analysis of cells within the myogenic compartment, defined as Lineage − /α7integrin + cells and subsequently refined to Lineage − /α7integrin + /CD9 + cells. With this multivariate algorithm six clusters were generated, based on the expression of known and previously unrecognized surface markers, and key myogenic transcription factors. To visualize the spatial relationships between the cell types within these X-shift clusters, 2,000 randomly sampled cells from each cluster were subjected to a force-directed layout [13] [14] [15] . The resultant map revealed that cells fell densely into three prominent clusters and were linked by sparsely populated paths (Fig. 1c) . Cells within the densely populated regions were characterized by differential expression of the myogenic transcription factors Pax7, Myf5, MyoD and Myogenin (Fig. 1d) , which are known to mark muscle stem cells, activated stem cells, committed and differentiated muscle cells, respectively 1 . The unique expression pattern of the myogenic transcription factors allowed us to infer developmental stage for these clusters, which we named stem cell population SC, based on high Pax7 expression, and progenitor cell populations P1 and P2, based on Myf5, MyoD and Myogenin expression (Fig. 1d) . The co-expression patterns of two surface markers identified in the screen, CD9, a tetraspanin 16, 17 , and CD104, an integrin [18] [19] [20] [21] [22] , distinctively defined these populations. SC and P1 were distinguished by differential expression levels of CD9 (intermediate in SC and high in P1), whereas P2 expressed high levels of both CD9 and CD104 (Fig. 1e) . These in vivo data were supported by the results of the flow cytometry screen in which CD9 was expressed at higher levels in myoblasts than in MuSCs ( Supplementary Fig. 1e ,f) and CD104 was expressed exclusively by myoblasts (Fig. 1a and Supplementary Fig. 1e) . Importantly, the combination of these two surface markers identified myogenic progenitors in vivo, a critical missing link between stem cells and differentiated muscle cells.
Data analysis by principal component analysis (PCA), a dimensionality reduction algorithm, revealed that the progenitor populations (P1 and P2) differ from the stem cell population (SC) on the basis of their protein co-expression patterns ( Supplementary  Fig. 1g) (Fig. 1f) . Importantly, the three X-shift clusters could be identified by manual gating, the gold standard of flow cytometry analysis, solely on the basis of the expression of CD9 and CD104 (Fig. 2a and Supplementary Fig. 1d ). Manual gating also revealed a rare population, P3 (Fig. 2a) , whose frequency was too low for functional assays. Therefore, these two markers now provide a sorting strategy to prospectively isolate stem and progenitor cell populations that represent landmarks of myogenesis, as confirmed by the differential expression of the myogenic transcription factors Pax7, Myf5, MyoD and Myogenin, shown in the third dimension (Fig. 2b) .
Quantification of each population, identified in the biaxial dot plot of CD9 by CD104, showed that SC comprised the highest fraction of Pax7
+ cells (Fig. 2c) , with the highest expression levels (Fig. 2d ). In contrast, P1 and P2 comprised the highest fraction of Myf5 + and Myogenin + cells (Fig. 2c) , with the highest expression levels (Fig. 2d ). P2 also comprised a small fraction of MyoD + cells (Fig. 2b-d ). These data are consistent with the identification of SC as the MuSC population and P1 and P2 as previously unrecognized progenitor populations (Fig. 1c-e) . Further, they suggest a model in which as cells transition from the stem cell state (SC) to the differentiated myogenic state, they sequentially upregulate the expression of CD9 and CD104, giving rise to P1 and then P2 (Fig. 1f) . In support of this model, Pax7 knockout (Pax7 −/− ) mice demonstrated a shift in the distribution of cell populations SC, P1, P2 and P3 (Fig. 2f) . Compared with wild-type controls, the fraction of cells in SC in Pax7 −/− mice was markedly diminished at the neonatal stage and progressively declined by 3 weeks of age (Fig. 2f,g ). At birth, the decrease in Pax7 −/− cells within the SC population was paralleled by an increase in the fraction of cells in P1 (Fig. 2g) , and was accompanied by alteration of a key signalling pathway involved in the regulation of myogenic commitment [23] [24] [25] [26] , as shown by increased phosphorylation of MAPKAPK2 ( Supplementary Fig. 2a ), a direct target of p38α/β MAPK (ref. 27 ). In one rare Pax7 −/− mouse that survived to three weeks of age, a majority of α7integrin + /CD9 + muscle cells were in P2 and P3. The cells expressed high levels of MyoD (Fig. 2f) and Myogenin ( Supplementary Fig. 2b ), and exhibited increased phosphorylation of MAPKAPK2 ( Supplementary Fig. 2a ), indicative of premature differentiation. Collectively, our data suggest that in Pax7 −/− muscle, stem cells are progressively lost, the stem cell state is not maintained, and committed cells are the prevalent population by three weeks of age, when the role of Pax7 is required and mutant mice start to die 28, 29 .
The identified progenitor populations originate from muscle stem cells and exhibit myogenic potential in vitro and in vivo To determine whether the progenitor populations were derived from MuSCs, we cultured α7integrin + /CD34 + MuSCs isolated from murine hindlimbs, and measured changes in the expression of CD9 and CD104 during commitment to differentiation. Sorted MuSCs were expanded on hydrogels for one week and then treated with Tibialis anterior (TA) and gastrocnemius (GA) muscles were triturated, digested to a single-cell suspension, stained with isotopechelated antibodies and run through the CyTOF instrument. Stained cells were passed through an inductively coupled plasma, atomized, ionized, and the elemental composition was mass measured. Signals corresponding to each elemental tag were correlated to the presence of the respective isotopic marker. Data were analysed using standard flow cytometry software and the clustering algorithm X-shift. (c) Live/Lineage − /α7integrin + /CD9 + cells gated from murine hindlimb muscles (TA and GA) were analysed with the X-shift algorithm yielding six clusters (colour-coded in blue, purple, light green, dark green, red and orange). These clusters were visualized using single-cell force-directed layout. Up to 2,000 cells were randomly selected from each X-shift cluster, each cell was connected to 30 nearest neighbours in the phenotypic space and the graph layout was generated using the ForceAtlas2 algorithm [13] [14] [15] (representative experiment, n = 3 mice; 4 independent experiments). proportion of each population within the Live/Lineage − /α7integrin + /CD9 + myogenic compartment in Pax7 −/− and WT muscle isolated from neonates (mean ± s.e.m. from n = 3 mice, 2 independent experiments) and 3 weekold-mice (n = 1 Pax7 −/− ; mean ± s.e.m. from n = 10 WT, 2 independent experiments). Multiple t-tests analysis with Bonferroni correction was used to determine difference between Pax7 −/− and WT neonates within populations SC, P1, P2. * , * * , * * * and * * * * represent statistical significance at P < 0.05, P < 0.01, P < 0.001 and P < 0.0001 respectively. NS, statistically non-significant. differentiation media for 2, 4 and 7 days respectively (Fig. 3a) . On day 2 of the assay, the majority of cells comprised stem cells (SC). Over the course of one week the fraction of cells bearing the P1 phenotype progressively increased from 1% to 27%, whereas cells bearing the P2 phenotype increased from 0.4% to 12% (Fig. 3a) . These results are consistent with a muscle stem cell of origin giving rise to sequential populations of myogenic progenitor cells that could now be distinguished by differential expression of CD9 and CD104.
To determine the functional capabilities of the myogenic progenitors in vitro and in vivo, two independent assays were designed. In the first assay, individual stem and progenitor cell populations were sorted, placed into culture for a week on hydrogel and then differentiated to induce fusion. Cells from both the stem cell population (SC) and progenitor cell populations (P1 and P2) retained proliferative capacity and successfully differentiated and fused in vitro ( Supplementary  Fig. 2d ). In the second assay, the regenerative potentials of the stem cell population (SC) and the progenitor cell populations (P1, P2) were each assessed in vivo using standard assays 10, 30 . Individual cell populations were isolated from GFP/Luciferase mice and transplanted into the irradiated TA muscles of NOD/SCID mice (Fig. 3b) . At 5 weeks posttransplant, the contribution of the donor cells to regenerated damaged tissue was determined by bioluminescence imaging (BLI) (Fig. 3b,c) . Based on engraftment frequencies and BLI signal intensity of the engrafted transplants, the regenerative potential of the populations was highest for SC and progressively lower for P1 and P2 (Fig. 3b,c) , consistent with the functional attributes of stem and two progressively more differentiated progenitor cell populations.
To visualize the MuSC (SC) to progenitor (P1, P2) transition in vivo we performed lineage tracing in response to acute injury, induced by notexin injection. In this scenario, Pax7CRE
ERT2 ROSA-LSL-tomato mice 31 were injected with tamoxifen for 5 consecutive days, and injected with notexin in the TA and GA muscles 10 days later. Tissue was harvested and cells were analysed by flow cytometry at day 6 post-injury (Fig. 3d) . Cell populations SC, P1 and P2 were identified on the basis of differential expression of CD9 and CD104 and analysed for the expression of tomato, indicative of prior Pax7 expression. In the pre-injury state, most tomato + cells were in SC (Fig. 3e,f and Supplementary Fig. 2e ). However, in response to injury, while the fraction of tomato + cells in SC remained elevated, there was a marked increase in the fraction of tomato + cells in P1 and P2 (Fig. 3e,f and Supplementary Fig. 2e ). Together, these in vitro and in vivo functional studies demonstrate that the identified progenitor populations originate from MuSCs, have myogenic potential, and exhibit distinct regenerative capacity in vivo.
Trajectory of activated stem cells to progenitor cells revealed by CyTOF analysis after acute muscle injury
To capture the progression of myogenesis in vivo and define the cellular and molecular dynamics of regeneration, we employed CyTOF analysis of skeletal muscle during an injury time course by notexin injection. To mark cells in S-phase and follow changes in proliferation, IdU was injected 8 h before tissue processing 32 (Fig. 4a) . Muscle tissue was digested to a single-cell suspension and stained with the CyTOF antibody panel described above (Fig. 1b and Supplementary  Table 1 ). Data analysis revealed that at day 3 post-injury the cells in population SC incorporated IdU, with a fraction exhibiting a concomitant increase in the expression of MyoD (Fig. 4b) . Consistent with the increased IdU incorporation, a marker of S-phase, there was a striking increase in the proportion of SC cells at day 3 postinjury. This was accompanied by a reduction in the proportion of P1 and P2 cells (Fig. 4c,d ). The sharp decline in the fraction of SC cells that incorporated IdU, from ∼52% ± 4% at day 3 post-injury to ∼9% ± 1% by day 6, and the minimal IdU incorporation into cells within P1 and P2 suggested that early after muscle injury, cells within SC are the most proliferative (Fig. 4b,e) .
The CyTOF technology enabled high-resolution molecular analysis of muscle stem and progenitor cell populations during the functional response to injury. A heatmap showing protein expression levels for each population revealed that at the steady state, cell surface markers CD44, a glycoprotein implicated in myoblast migration and differentiation 33 , and CD98, an amino acid transporter upregulated in human skeletal muscle in response to increased availability of essential amino acids 34 , together with myogenic transcription factors Myf5, MyoD and Myogenin, were expressed at higher levels in P1 and P2 compared with SC (Fig. 5a ). Following injury, the most striking increases for IdU incorporation were seen on day 3 within population SC. Additionally, CD44 and CD98 were transiently co-expressed on day 3, concomitant with the transcription factor MyoD (Fig. 5b) , in about 50% of the SC population (Fig. 5c,d ). All of these proteins returned to pre-injury levels by day 6 (Fig. 5b) , indicating that they identify a molecular signature of the activated stem cell state. PCA analysis (Fig. 5e ), corroborated by a supervised clustering analysis enforcing a two-cluster solution ( Supplementary Fig. 3a) , showed that at day 3 individual populations cluster away from day 0 and day 6, confirming that significant cellular and molecular alterations occur by day 3 and subside to a level approximating the uninjured state by day 6.
To gain increased resolution into the dynamic changes that occur during the 6 day course of recovery from injury, we applied the unsupervised X-shift analysis approach described above (Fig. 1c-e) . High-dimensional X-shift analysis of the mass cytometry data set over time allowed us to construct a molecular map of regeneration as a continuum. A force-directed layout visualization combining cells from X-shift clusters at all time points revealed three dense regions that could be distinguished by the expression pattern of the surface markers CD9 and CD104 (Fig. 6a) . Analysis of the regeneration map over time revealed that the occupancy of cells in the dense regions differed at each time point (Fig. 6b) , which is consistent with the findings shown in Fig. 4c,d . Moreover, the single-cell spatial resolution enabled by X-shift analysis paired with single-cell force-directed layout data visualization uncovered dynamic changes in the expression of Pax7, MyoD and Myogenin as well as IdU incorporation, revealing distinct patterns and marking a differentiation trajectory (Fig. 6c,d ). At the pre-injury state (day 0) there was no IdU incorporation into any of the stem or progenitor cell populations, consistent with the literature 35, 36 . During the early phase of recovery from injury (day 3), cells in population SC transited to a different location on the map, characterized by high IdU incorporation (Fig. 6c) . MyoD upregulation clearly marked a portion of these cells and its elevated expression persisted during the late phase of regeneration (day 6), when MyoD expression partially coincided with Myogenin upregulation (Fig. 6d) . Myogenin expression, during the late phase of recovery from injury extended in a unique pattern along the path that progresses from SC to P2, delineating a trajectory * * * * * (e) TA muscle isolated from uninjured and injured mice (day 6 post-injury) was digested to a single-cell suspension and stained using fluorescently conjugated antibodies against lineage markers, α7integrin, CD9 and CD104. Representative biaxial dot plots of CD9 by CD104 coloured by channel show the expression of tdTomato in populations SC, P1 and P2 at day 0 and day 6 post-injury (n = 3 mice per condition). (f) The scatter plot shows the fraction of tomato + cells in populations SC, P1 and P2 at day 0 and day 6 post-injury (mean ± s.d. from n = 3 mice per condition). Multiple t-tests analysis with Bonferroni correction was used to determine the difference between the two groups (uninjured and injured) within populations SC, P1 and P2. * , * * and * * * * represent statistical significance at P < 0.05, P < 0.01 and P < 0.0001. NS, statistically non-significant.
of myogenic differentiation in vivo, which is highlighted in the merged panel for days 0, 3 and 6 (Fig. 6d, lower right panel, arrows) . The MyoD-negative fraction of SC showed a distinctive upregulation of Pax7, indicating a return to quiescence (Fig. 6c,d , upper right panels, arrows). In summary, unsupervised X-shift analysis of the myogenic compartment during the time course of recovery from acute injury The line represents mean ± s.e.m. Statistical analyses were performed using two-way ANOVA test with significance level determined by Bonferroni's multiple comparisons test. * , * * * and * * * * represent statistical significance at P < 0.05, P < 0.001 and P < 0.0001 respectively. NS, statistically non-significant.
enabled us to visualize the spatial relationships between MuSCs (SC) and the identified progenitor cells (P1, P2), and uncover a dynamic myogenic trajectory that delineated cell-state transitions. Together, these data suggest an in vivo myogenic regeneration model in which activated MuSCs (SC) give rise to progeny, some of which express high levels of MyoD, commit and differentiate into progenitors (P1, P2), while others upregulate Pax7 expression and go back to quiescence to replenish the stem cell pool. Importantly, we have identified two surface markers, CD9 and CD104, whose differential expression allowed us to capture these myogenic progenitor populations in vivo.
DISCUSSION
Previous work has highlighted the potential of single-cell mass cytometry to resolve the heterogeneity in the haematopoietic compartment, based on cell surface markers 4, 5 . Here we pioneered the application of CyTOF to simultaneously analyse cell surface markers and key myogenic transcription factors. This enabled us to resolve the heterogeneity of the myogenic compartment, yielding previously unknown progenitor cell populations, and delineating a myogenic progression from stem to progenitor cells in vivo in skeletal muscle. We showed that these progenitor cell populations originate from Pax7 + stem cells and exhibit myogenic function in vitro and in vivo, by a combination of lineage tracing and functional assays of myogenesis.
High-dimensional CyTOF analysis of skeletal muscle resolved the intermediate stages of myogenesis at an unprecedented level of detail and revealed the complex relationship between stem and progenitor states during regeneration, suggesting that these states are in constant flux. For example, during recovery from acute injury, SC, the most stem-like population, is activated to give rise to subsets that are MyoD + and MyoD − , the latter returning to occupy a ground state identified by high Pax7. Indeed, X-shift clustering analysis combined with single-cell force-directed layout visualization of the myogenic compartment provided a high-resolution lens that revealed the cellular and molecular dynamics defining the response to acute muscle injury. It uncovered unanticipated heterogeneity within the SC compartment, leading to the identification of a molecular signature of the activated stem cell state, in addition to a differentiation trajectory from MuSCs (SC) to progenitor cells (P1 and P2) that could not have previously been envisioned. Previous studies suggest that CD9, the myogenic progenitor marker identified here, has a functional role in the activation of the myogenic program. A member of the tetraspanin family, CD9 plays a key role in signal transduction and has been implicated in various biological processes, such as cell migration, homing, adhesion and fusion 37 .
In systems other than muscle, CD9 has been shown to negatively regulate ADAM10 and ADAM17, two metalloproteases involved in activation of Notch signalling [38] [39] [40] , an essential pathway for MuSC maintenance 41 . Therefore, we speculate that upregulation of CD9 at the transition from MuSC (SC) to progenitor cell (P1, P2) could lead to indirect inhibition of Notch signalling via ADAMs, initiating commitment and differentiation. Another tetraspanin, CD82, has been recently identified on the surface of human muscle stem and progenitor cells 42, 43 . Due to its low expression range in murine muscle cells ( Supplementary Fig. 3b ), CD82 cannot faithfully discriminate the cell populations described here (SC, P1 and P2).
CD104, which marks progenitor population P2, is also known as integrin beta 4 and is a receptor for laminins 18 . It plays a key structural role in the hemidesmosomes of epithelial cells 44 . Like other integrins it mediates cell-matrix, cell-cell adhesion and activates signalling pathways that regulate cell growth. CD104 has been implicated in the epithelial to mesenchymal transition 20 , tumour progression 21 and cellular reprogramming to pluripotency 15 . In skeletal muscle, it has been shown to mark a heterogeneous cell population, which CD104 alone could not resolve to functional homogeneous subsets 22 . The approach described here provides a tool for identifying and isolating myogenic progenitors in vivo and therefore offers the opportunity to uncover key factors and the downstream signalling pathways that govern cell fate decisions and regulate the balance between cell states, during muscle homeostasis and regeneration. Understanding the fundamental biology and manipulating these cell states ex vivo will be instrumental for overcoming barriers to successful transplantation and for optimizing muscle cell therapeutic strategies. Furthermore, high-resolution single-cell studies of the signalling pathways that modulate the transition from MuSC to committed and differentiated muscle cell may provide insight into the mechanisms underlying the development of rhabdomyosarcoma, a highly heterogeneous tumour that affects children 45 . While here we present the simultaneous measurements of transcription factors and cell surface proteins, the complexity can be extended further. Singlecell mass cytometry has the unique attribute, over other available single-cell approaches, to study post-translational modifications and cell signalling in complex populations as they change over time.
In summary, the work presented here sets the stage for addressing questions that were previously beyond reach, such as uncovering how stem and progenitor cell interaction regulates tissue regeneration 46, 47 , and establishes a foundation for investigating the cellular and molecular defects that characterize ageing and muscle diseases. Such studies may reveal alterations in population distribution or cell signalling of fundamental interest and potential utility in the identification of novel therapeutic targets. These results provide a paradigm for other studies of solid tissues and their characteristic kinetic changes in the course of development. Finally, our work paves the way for high-resolution analysis of other regenerating tissues, with the potential to discover as yet unknown stem and progenitor cell populations with a role in development and disease.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper. 
